Department of Anesthesiology, Allegheny-Singer Research Institute, Pittsburgh, PA 15212, USA.
Brain Res. 2013 Aug 21;1527:199-208. doi: 10.1016/j.brainres.2013.06.012. Epub 2013 Jun 19.
This study addresses the spatial relation between local Na(+) and K(+) imbalances in the ischemic core in a rat model of focal ischemic stroke. Quantitative [Na(+)] and [K(+)] brain maps were obtained by (23)Na MRI and histochemical K(+) staining, respectively, and calibrated by emission flame photometry of the micropunch brain samples. Stroke location was verified by diffusion MRI, by changes in tissue surface reflectivity and by immunohistochemistry with microtubule-associated protein 2 antibody. Na(+) and K(+) distribution within the ischemic core was inhomogeneous, with the maximum [Na(+)] increase and [K(+)] decrease typically observed in peripheral regions of the ischemic core. The pattern of the [K(+)] decrease matched the maximum rate of [Na(+)] increase ('slope'). Some residual mismatch between the sites of maximum Na(+) and K(+) imbalances was attributed to the different channels and pathways involved in transport of the two ions. A linear regression of the [Na(+)]br vs. [K(+)]br in the samples of ischemic brain indicates that for each K(+) equivalent leaving ischemic tissue, 0.8±0.1 Eq, on average, of Na(+) enter the tissue. Better understanding of the mechanistic link between the Na(+) influx and K(+) egress would validate the (23)Na MRI slope as a candidate biomarker and a complementary tool for assessing ischemic damage and treatment planning.
本研究探讨了局灶性缺血性卒中大鼠模型中缺血核心内局部钠离子(Na(+))和钾离子(K(+))失衡的空间关系。通过(23)Na MRI 和组织化学 K(+)染色分别获得定量 [Na(+)] 和 [K(+)] 脑图谱,并通过微钻脑样本的发射火焰光度法进行校准。通过扩散 MRI、组织表面反射率的变化和微管相关蛋白 2 抗体的免疫组织化学来验证卒中位置。缺血核心内的 Na(+) 和 K(+) 分布不均匀,最大 [Na(+)] 增加和 [K(+)] 减少通常发生在缺血核心的外周区域。[K(+)] 减少的模式与 [Na(+)] 增加的最大速率(“斜率”)相匹配。最大 Na(+) 和 K(+) 失衡部位之间的一些剩余不匹配归因于两种离子转运所涉及的不同通道和途径。缺血脑组织样本中 [Na(+)]br 与 [K(+)]br 的线性回归表明,对于离开缺血组织的每个 K(+) 当量,平均有 0.8±0.1 Eq 的 Na(+) 进入组织。更好地理解 Na(+) 内流和 K(+) 外排之间的机制联系将验证 (23)Na MRI 斜率作为候选生物标志物,并为评估缺血性损伤和治疗计划提供补充工具。